Shandong Lukang Pharmaceutical Co., Ltd. Class ASSE: 600789

Announcement on the Holding Subsidiary Obtaining the Supplementary Application Approval Notice for Methocarbamol Injection and Becoming the Marketing Authorization Holder of the Drug

· Issued by Shandong Lukang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Holding Subsidiary Obtaining the Supplementary Application Approval Notice for Methocarbamol Injection and Becoming the Marketing Authorization Holder of the Drug

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis